CLGN CollPlant Biotechnologies Ltd

BEARISH Impact: 6/10 EFFECT
Horizon immediate Filed Apr 22, 2026 Processed 1mo ago SEC 9999999995-26-001268
IPO/offering going effective
Latest settled — T+20d
CLGN ▲ +7.14% at T+20d
SHORT call ✗ call lost -7.14% · α vs SPY -3.98% · entry $0.3920 → $0.4200
Next anchor: T+60d in 5w
Last close $0.3390 (close Jun 12) · +13.52% from $0.3920 entry (call sign-flipped)
Entry anchored
Apr 21, 03:58 PM ET
via Databento tick
T+1d
-8.93%
call +8.93% · α +8.53%
$0.3570
settled 8w ago
T+5d
-3.06%
call +3.06% · α +3.12%
$0.3800
settled 7w ago
T+20d
+7.14%
call -7.14% · α -3.98%
$0.4200
settled 26d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

The SEC has declared effective CollPlant Biotechnologies Ltd's F-1 registration statement, enabling the resale of up to 3,296,000 ordinary shares by selling shareholders. This is not an IPO but a secondary offering of existing warrants and shares, with no proceeds going to the company.

Actionable Insight

Traders should anticipate potential downward pressure on CLGN shares as selling shareholders may begin offloading shares immediately. Monitor for warrant exercise activity, which would further dilute shares outstanding. The declining stock price since the initial filing suggests weakening market sentiment ahead of this unlock.

Key Facts

  • SEC declared effective the F-1 registration (File No. 333-294738) on April 21, 2026
  • Registration covers resale of 3,296,000 ordinary shares by selling shareholders
  • Shares consist of 1,600,000 from Series A warrants, 1,600,000 from Series B warrants, and 96,000 from placement agent warrants, all issued February 6, 2026
  • Company will not receive proceeds from the resale, though it may receive funds if warrants are exercised on a cash basis
  • Last reported share price was $0.29 on April 14, 2026, down from $0.62 on March 27, 2026

Financial Impact

Potential overhang of 3,296,000 shares representing immediate dilution risk if warrants are exercised; current market value of shares at $0.29 is approximately $955,840

dilutionshare countmarket capitalization

Risk Factors

  • Immediate selling pressure from 3.3M share overhang
  • Further dilution if warrants are exercised on a cash basis

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001268
Document: 9999999995-26-001268-index.html9999999995-26-001268
Document: 9999999995-26-001268.txt9999999995-26-001268
3 reports for CLGN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CLGN — sortable, filterable
Type Now
May 29, 2026
16d ago
6-K
BEARISH ★ 7/10
$0.4020 $0.3710▲ +7.71%▲ +5.19%$0.3390 (+15.67%)
Apr 22, 2026
7w ago
EFFECT
BEARISH ★ 6/10
$0.3920 $0.3800▲ +3.06%▲ +3.12%$0.3390 (+13.52%)
Apr 13, 2026
8w ago
6-K
BEARISH ★ 7/10
$0.3220 $0.3710▼ −15.22%▼ −11.92%$0.3390 (−5.28%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 4h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access